DBVT
DBV Technologies S.A.
NASDAQ · Healthcare · Biotechnology · FR
$13.47
−1.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 60.37x
- P/S forward
- 96.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.28x
- Price / sales
- —
- Price / cash flow
- -4.24x
Enterprise value
- Enterprise value
- $692.6M
- EV / sales
- —
- EV / EBITDA
- -4.02x
- EV / EBIT
- -3.82x
- Market cap
- $846.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026